Showing 1771-1780 of 2216 results for "".
- Anti-Aging Products Services, Devices Market Experiencing Significant Growthhttps://modernaesthetics.com/news/anti-aging-products-services-devices-market-experiencing-significant-growth/2473618/New research shows the Anti-Aging Products Services and Devices Market is experiencing significant growth. The surge is fueled by consumers desire to look and feel young. The industry’s current valuation is at $60.76 billion in 2024, according to a revised market report by F
- Demand for Minimally Invasive Procedures Contributing to Medical Laser Technologies Surgehttps://modernaesthetics.com/news/demand-for-minimally-invasive-procedures-contributing-to-medical-laser-technologies-surge/2473617/The global market for medical laser technologies is forecasted to reach $6.4 billion in 2024, according to research from the Medical Laster Technologies – A Global Market Overview. The report explores the market value from 2020 to 2029. Research found the medical laser techn
- DailyMail.com Highlight’s Plastic Surgeon’s Warning on Lip Fillerhttps://modernaesthetics.com/news/dailymailcom-highlights-plastic-surgeons-warning-on-lip-filler/2473611/Britain's Daily Mail featured a top plastic surgeon warning people to be careful when getting lip filler after two friends revealed shocking results from injections. Deepak Dugar, MD, is a board-certified plastic surgeon and has treated celebrity patients, including Ti
- Allergan Aesthetics Launches Payment Plan Program in Effort to Make Injectables More Affordablehttps://modernaesthetics.com/news/allergan-aesthetics-launches-payment-plan-program-in-effort-to-make-injectables-more-affordable/2473610/Patients seeking aesthetic treatments and products now have the option to pay over-time. Allergan Aesthetics, an AbbVie company, launched Alle Payment Plans, powered by Cherry, on Thursday. Patients can use the payment plan for treatments including Botox and the Juvéde
- United Aesthetics Alliance appoints new chief executive officer, chief development officerhttps://modernaesthetics.com/news/united-aesthetics-alliance-appoints-new-chief-executive-officer-chief-development-officer/2473608/United Aesthetics Alliance (UAA) announced it has appointed Thomas Thill as chief executive officer and Benjamin Herbert as chief development officer to lead the company’s go-forward growth strategy. As an experienced healthcare leader, Thill joins UAA to build market-leadin
- Cutera Academy Starts Stronghttps://modernaesthetics.com/news/cutera-academy-starts-strong/2473606/Cutera, Inc. announced positive initial feedback from its recently launched Cutera Academy, a comprehensive educational program designed to enhance provider expertise and practice success with AviClear®. “At Cutera, we believe in the power of partnerships,” Taylor Harris
- Cosmetic Surgery, Procedure Devices Market To Grow By $7.95Bhttps://modernaesthetics.com/news/cosmetic-surgery-procedure-devices-market-expected-to-grow-by-795b-over-next-4-years/2473603/New research forecasts the cosmetic surgery and procedure devices market will grow by $7.95 billion from 2024 to 2028. Technavio estimates the market to increase at a compound annual growth rate of 10.45% over the next four years. An increase of medical conditions that require cos
- AVAVA Secures $35M in Financing to Support Expansion of Laser Technologyhttps://modernaesthetics.com/news/avava-secures-35m-in-financing-to-support-expansion-of-laser-technology/2473591/AVAVA, Inc. announced a $35 million funding has been secured for its focus on advancing image-guided intradermal laser products that are safe and effective for all skin tones. The financin
- Expanscience Unveils its First Active Ingredient from Regenerative Agriculturehttps://modernaesthetics.com/news/expanscience-unveils-its-first-active-ingredient-regenerative-agriculture/2473590/Expanscience Laboratories recently launched GAÏALINE®, which is the company’s first active ingredient derived from soil conservation agriculture and is effective on both hair
- Exosome Diagnostics and Therapeutics Market Expected to Surgehttps://modernaesthetics.com/news/exosome-diagnostics-and-therapeutics-market-expected-to-surge/2473588/Emerging potential of exosome-based liquid biopsy is a primary factor driving the growth of the market. The Exosome Diagnostics and Therapeutics market is expected to surge from $59 million in 2024 to $6.848 billion by 2032 with a compound annual growth rate of 108.9%. The exosome